赛升药业(300485.SZ)股东马丽和刘淑芹拟合计减持不超2%股份

Group 1 - The core point of the article is that shareholders of Sai Sheng Pharmaceutical plan to reduce their holdings by a total of up to 9.633 million shares, which represents no more than 2% of the company's current total share capital [1] Group 2 - The reduction in shareholding will occur between October 21, 2025, and January 20, 2026, through centralized bidding and block trading methods [1]